EDIT (Editas) Earnings per share for the trailing year

Public company logo of Editas Medicine Inc (EDIT)

The investment attractiveness of Editas Medicine, Inc. (EDIT) is based on unique CRISPR technologies and long-term intellectual property protection, which ensures a steady inflow of capital. The stock's price history confirms the current EPS at 73.70. Business resilience depends on the outcome of legal disputes and the safety of the therapies. The company is currently scaling innovative treatment methods for vision and blood pathologies.

Editas (EDIT) Net earnings per share (EPS TTM): for the period 02/11/2024 - 11/18/2026

editasmedicine.com - analytical breakdowns and key metrics (EDIT)

- market price and analyst price targets:
- business market valuation indicators:
Fundamental company valuation:Editas Medicine, Inc.
Finished products of Editas Medicine, Inc.

Professional selection of blue-chip assets requires rigorous filtering through the lens of capital efficiency. This indicator measures the annual change in net income per share (TTM), identifying a business's ability to outpace cost inflation. For Editas Medicine, Inc. (EDIT), as a CRISPR technology pioneer, this metric reflects the balance between colossal R&D expenditures and the capitalization of scientific superiority. The historical EPS YoY TTM delta allows for an assessment of the sustainability of the model for the radical treatment of genetic pathologies.

Competitor analysis for Editas Medicine, Inc.

Earnings per share for the trailing year TEM (Tempus AI Inc)|QGEN (Qiagen Group) - Net earnings per share for the last 12 months|Earnings per one share for the last 12 months IONS (Ionis Pharma)|Earnings per share for the last twelve months Repligen|Earnings per share for the last twelve months RNA|Net earnings per share (EPS TTM) CRSP|Earnings per share for the last twelve months WGS (GeneDx)|Ultragenyx Pharmaceutical - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Beam Tx BEAM|Sarepta Therapeutics - Net earnings per share (EPS TTM)|Twist Bioscience (TWST) - Net earnings per share for the last 12 months|TXG: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Net earnings per share (EPS TTM)|BLFS (BioLife Corp) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Wave Life Sciences Ltd. (WVE)|Earnings per share for the last four quarters MAZE|sionnatx.com - Net earnings per share for the last 12 months|Earnings per share for the trailing year PRME|TSHA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months RGNX|Net earnings per share for the last 12 months SLDB|Net earnings per share (EPS TTM) Ocugen Inc|Earnings per share for the last twelve months PacBio Corp (PACB)|Net earnings per share for the last four quarters Benitec Corp|Net earnings per share (EPS TTM) DSGN (Design Therapeutics, Inc.)|Net earnings per share (EPS TTM) rocketpharma.com RCKT|4DMT - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Earnings per share for the last twelve months|Earnings per share for the last 12 months SLN|Net earnings per share for the last 12 months PRQR|Net earnings per one share for the last twelve months Codexis CDXS|Earnings per share for the last twelve months Sangamo BioSciences (SGMO)|Net earnings per share (EPS TTM) Nautilus Biotechnology Inc (NAUT)|Net earnings per share (EPS TTM) MGX (Metagenomi Inc.)|Precision BioSciences - Earnings per share for the last twelve months|generationbio.com - Net earnings per share (EPS TTM)|BOLD: Earnings per share for the last twelve months|XCUR (Exicure Corp) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months IMNN|Earnings per share for the last twelve months RXi Pharmaceuticals|Net earnings per share (EPS TTM) mustangbio.com|Net earnings per share (EPS TTM) RNAZ|Earnings per share for the last twelve months BNGO (Bionano Genomics)|Earnings per share for the last twelve months Applied DNA Sciences APDN|Net earnings per share for the last four quarters bluebird bio Inc. (BLUE)|IPA - Earnings per share for the last twelve months|Earnings per share for the trailing year OMGA (Omega Therapeutics)|OMIC: Net earnings per share (EPS TTM)|RGLS (Regulus Therapeutics Inc.) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Syros Pharmaceuticals Inc.|Telesis Bio Inc. (TBIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months traconpharma.com (TCON)|Earnings per share for the last four quarters UBX